Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06676761

Outcomes of a Novel Technique Minimal Scar Mastectomy

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
KK Women's and Children's Hospital · Other Government
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Nipple sparing mastectomy is oncologically safe and has a good cosmetic outcome. However, nipple sparing mastectomy was conventionally performed with reconstruction. Minimal scar mastectomy (MSM) is a novel technique which could allow women, with non-ptotic breasts, who do not want reconstruction, to conserve their nipple areolar complex (NAC) and avoid the transverse scar associated with modified radical mastectomy. This is the first study on the oncologic and surgical outcomes of MSM.

Conditions

Interventions

TypeNameDescription
PROCEDUREnipple sparing mastectomy without reconstructionnipple sparing mastectomy was conventionally performed with reconstruction. we aim to study the outcomes in the group of patients with Minimal scar mastectomy (MSM) who have nipple sparing mastectomy without reconstruction

Timeline

Start date
2017-03-01
Primary completion
2030-12-31
Completion
2030-12-31
First posted
2024-11-06
Last updated
2024-11-06

Locations

2 sites across 1 country: Singapore

Source: ClinicalTrials.gov record NCT06676761. Inclusion in this directory is not an endorsement.

Outcomes of a Novel Technique Minimal Scar Mastectomy (NCT06676761) · Clinical Trials Directory